CMP - Update on fulfilment of conditions precedent relating to the Scheme of Arrangement CIPLA MEDPRO SOUTH AFRICA LIMITED CIPLA LIMITED (Incorporated in the Republic of South Africa) (Incorporated in India) (Registration number 2002/018027/06) (Registration number 11-2380) Share code: JSE Limited - CMP Share codes: BSE Limited - 500087 ISIN: ZAE000128179 National Stock Exchange of India (“Cipla Medpro” or the "Company") Limited – CIPLA EQ ISIN Number: INE059A01026 (“Cipla India”) UPDATE ON FULFILMENT OF CONDITIONS PRECEDENT RELATING TO THE SCHEME OF ARRANGEMENT In the circular posted to shareholders on 15 April 2013 (“Circular”), shareholders were advised that the implementation of the Scheme was conditional upon the fulfilment of certain conditions precedent, as detailed therein. On 15 May 2013 and 20 June 2013, shareholders were provided with updates on the status of the fulfilment of the conditions precedent. Shareholders are now advised that further conditions precedent have been fulfilled or waived as follows: - the approval for the transaction by the Namibian competition authority has been obtained; and - Cipla India has waived the requirement that approval be obtained from the COMESA competition authority. Accordingly, receipt of a compliance certificate from the Takeover Regulation Panel (“TRP”) is the only remaining condition precedent required to be fulfilled for the implementation of the Scheme of Arrangement. Application has today been made to the TRP for such clearance certificate. A finalisation announcement and closing timetable will be published on the Stock Exchange News Service (“SENS”) of the JSE Limited (“JSE”) and in the South African press once the clearance certificate is received (being the date on which the last of the conditions precedent to the Scheme of Arrangement will have been met), currently anticipated to be on 28 June 2013. The effect of the above is that the updated timetable will in all likelihood reflect the same or similar closing dates to those in the Circular. Johannesburg 26 June 2013 Financial Advisor and Transaction Sponsor to Legal Advisor to Cipla Medpro Cipla Medpro ABSA (acting through its Corporate and Norton Rose Fulbright South Africa Investment Banking division) Financial Advisor to Cipla India Legal Advisor to Cipla India Morgan Stanley South Africa (Pty) Limited Webber Wentzel Merchant Bank to Cipla India Sponsor to Cipla Medpro Rand Merchant Bank Nedbank Capital Independent Expert to the Cipla Medpro Independent Board Bridge Capital Advisors (Pty) Limited Date: 26/06/2013 05:06:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.